Global Hepatitis B Vaccines Market Growth 2023-2029

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

LPI (LP Information)' newest research report, the “Hepatitis B Vaccines Industry Forecast” looks at past sales and reviews total world Hepatitis B Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Hepatitis B Vaccines sales for 2023 through 2029. With Hepatitis B Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis B Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Hepatitis B Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis B Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hepatitis B Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis B Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis B Vaccines.

The global Hepatitis B Vaccines market size is projected to grow from US$ 999.6 million in 2022 to US$ 1137.8 million in 2029; it is expected to grow at a CAGR of 1137.8 from 2023 to 2029.

In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.

The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.

Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Yeast Derived
    CHO Derived

Segmentation by application
    Children
    Adult

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    GSK
    NCPC
    Merck
    Bio Kangtai
    Dynavax
    Hissen
    KM Biologics
    LG Life Sciences
    Serum Institute

Key Questions Addressed in this Report
What is the 10-year outlook for the global Hepatitis B Vaccines market?
What factors are driving Hepatitis B Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis B Vaccines market opportunities vary by end market size?
How does Hepatitis B Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Hepatitis B Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Hepatitis B Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Yeast Derived
    Table 4. Major Players of CHO Derived
    Table 5. Global Hepatitis B Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 6. Global Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
    Table 7. Global Hepatitis B Vaccines Revenue by Type (2018-2023) & ($ million)
    Table 8. Global Hepatitis B Vaccines Revenue Market Share by Type (2018-2023)
    Table 9. Global Hepatitis B Vaccines Sale Price by Type (2018-2023) & (USD/Doses)
    Table 10. Global Hepatitis B Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 11. Global Hepatitis B Vaccines Sales Market Share by Application (2018-2023)
    Table 12. Global Hepatitis B Vaccines Revenue by Application (2018-2023)
    Table 13. Global Hepatitis B Vaccines Revenue Market Share by Application (2018-2023)
    Table 14. Global Hepatitis B Vaccines Sale Price by Application (2018-2023) & (USD/Doses)
    Table 15. Global Hepatitis B Vaccines Sales by Company (2018-2023) & (M Doses)
    Table 16. Global Hepatitis B Vaccines Sales Market Share by Company (2018-2023)
    Table 17. Global Hepatitis B Vaccines Revenue by Company (2018-2023) ($ Millions)
    Table 18. Global Hepatitis B Vaccines Revenue Market Share by Company (2018-2023)
    Table 19. Global Hepatitis B Vaccines Sale Price by Company (2018-2023) & (USD/Doses)
    Table 20. Key Manufacturers Hepatitis B Vaccines Producing Area Distribution and Sales Area
    Table 21. Players Hepatitis B Vaccines Products Offered
    Table 22. Hepatitis B Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Hepatitis B Vaccines Sales by Geographic Region (2018-2023) & (M Doses)
    Table 26. Global Hepatitis B Vaccines Sales Market Share Geographic Region (2018-2023)
    Table 27. Global Hepatitis B Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 28. Global Hepatitis B Vaccines Revenue Market Share by Geographic Region (2018-2023)
    Table 29. Global Hepatitis B Vaccines Sales by Country/Region (2018-2023) & (M Doses)
    Table 30. Global Hepatitis B Vaccines Sales Market Share by Country/Region (2018-2023)
    Table 31. Global Hepatitis B Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
    Table 32. Global Hepatitis B Vaccines Revenue Market Share by Country/Region (2018-2023)
    Table 33. Americas Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 34. Americas Hepatitis B Vaccines Sales Market Share by Country (2018-2023)
    Table 35. Americas Hepatitis B Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 36. Americas Hepatitis B Vaccines Revenue Market Share by Country (2018-2023)
    Table 37. Americas Hepatitis B Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 38. Americas Hepatitis B Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 39. APAC Hepatitis B Vaccines Sales by Region (2018-2023) & (M Doses)
    Table 40. APAC Hepatitis B Vaccines Sales Market Share by Region (2018-2023)
    Table 41. APAC Hepatitis B Vaccines Revenue by Region (2018-2023) & ($ Millions)
    Table 42. APAC Hepatitis B Vaccines Revenue Market Share by Region (2018-2023)
    Table 43. APAC Hepatitis B Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 44. APAC Hepatitis B Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 45. Europe Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 46. Europe Hepatitis B Vaccines Sales Market Share by Country (2018-2023)
    Table 47. Europe Hepatitis B Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 48. Europe Hepatitis B Vaccines Revenue Market Share by Country (2018-2023)
    Table 49. Europe Hepatitis B Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 50. Europe Hepatitis B Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 51. Middle East & Africa Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 52. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country (2018-2023)
    Table 53. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 54. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country (2018-2023)
    Table 55. Middle East & Africa Hepatitis B Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 56. Middle East & Africa Hepatitis B Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 57. Key Market Drivers & Growth Opportunities of Hepatitis B Vaccines
    Table 58. Key Market Challenges & Risks of Hepatitis B Vaccines
    Table 59. Key Industry Trends of Hepatitis B Vaccines
    Table 60. Hepatitis B Vaccines Raw Material
    Table 61. Key Suppliers of Raw Materials
    Table 62. Hepatitis B Vaccines Distributors List
    Table 63. Hepatitis B Vaccines Customer List
    Table 64. Global Hepatitis B Vaccines Sales Forecast by Region (2024-2029) & (M Doses)
    Table 65. Global Hepatitis B Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 66. Americas Hepatitis B Vaccines Sales Forecast by Country (2024-2029) & (M Doses)
    Table 67. Americas Hepatitis B Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 68. APAC Hepatitis B Vaccines Sales Forecast by Region (2024-2029) & (M Doses)
    Table 69. APAC Hepatitis B Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 70. Europe Hepatitis B Vaccines Sales Forecast by Country (2024-2029) & (M Doses)
    Table 71. Europe Hepatitis B Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 72. Middle East & Africa Hepatitis B Vaccines Sales Forecast by Country (2024-2029) & (M Doses)
    Table 73. Middle East & Africa Hepatitis B Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. Global Hepatitis B Vaccines Sales Forecast by Type (2024-2029) & (M Doses)
    Table 75. Global Hepatitis B Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 76. Global Hepatitis B Vaccines Sales Forecast by Application (2024-2029) & (M Doses)
    Table 77. Global Hepatitis B Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 78. GSK Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 79. GSK Hepatitis B Vaccines Product Portfolios and Specifications
    Table 80. GSK Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 81. GSK Main Business
    Table 82. GSK Latest Developments
    Table 83. NCPC Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 84. NCPC Hepatitis B Vaccines Product Portfolios and Specifications
    Table 85. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 86. NCPC Main Business
    Table 87. NCPC Latest Developments
    Table 88. Merck Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 89. Merck Hepatitis B Vaccines Product Portfolios and Specifications
    Table 90. Merck Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 91. Merck Main Business
    Table 92. Merck Latest Developments
    Table 93. Bio Kangtai Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 94. Bio Kangtai Hepatitis B Vaccines Product Portfolios and Specifications
    Table 95. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 96. Bio Kangtai Main Business
    Table 97. Bio Kangtai Latest Developments
    Table 98. Dynavax Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 99. Dynavax Hepatitis B Vaccines Product Portfolios and Specifications
    Table 100. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 101. Dynavax Main Business
    Table 102. Dynavax Latest Developments
    Table 103. Hissen Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 104. Hissen Hepatitis B Vaccines Product Portfolios and Specifications
    Table 105. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 106. Hissen Main Business
    Table 107. Hissen Latest Developments
    Table 108. KM Biologics Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 109. KM Biologics Hepatitis B Vaccines Product Portfolios and Specifications
    Table 110. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 111. KM Biologics Main Business
    Table 112. KM Biologics Latest Developments
    Table 113. LG Life Sciences Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 114. LG Life Sciences Hepatitis B Vaccines Product Portfolios and Specifications
    Table 115. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 116. LG Life Sciences Main Business
    Table 117. LG Life Sciences Latest Developments
    Table 118. Serum Institute Basic Information, Hepatitis B Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 119. Serum Institute Hepatitis B Vaccines Product Portfolios and Specifications
    Table 120. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2023)
    Table 121. Serum Institute Main Business
    Table 122. Serum Institute Latest Developments
List of Figures
    Figure 1. Picture of Hepatitis B Vaccines
    Figure 2. Hepatitis B Vaccines Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Hepatitis B Vaccines Sales Growth Rate 2018-2029 (M Doses)
    Figure 7. Global Hepatitis B Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Hepatitis B Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Yeast Derived
    Figure 10. Product Picture of CHO Derived
    Figure 11. Global Hepatitis B Vaccines Sales Market Share by Type in 2022
    Figure 12. Global Hepatitis B Vaccines Revenue Market Share by Type (2018-2023)
    Figure 13. Hepatitis B Vaccines Consumed in Children
    Figure 14. Global Hepatitis B Vaccines Market: Children (2018-2023) & (M Doses)
    Figure 15. Hepatitis B Vaccines Consumed in Adult
    Figure 16. Global Hepatitis B Vaccines Market: Adult (2018-2023) & (M Doses)
    Figure 17. Global Hepatitis B Vaccines Sales Market Share by Application (2022)
    Figure 18. Global Hepatitis B Vaccines Revenue Market Share by Application in 2022
    Figure 19. Hepatitis B Vaccines Sales Market by Company in 2022 (M Doses)
    Figure 20. Global Hepatitis B Vaccines Sales Market Share by Company in 2022
    Figure 21. Hepatitis B Vaccines Revenue Market by Company in 2022 ($ Million)
    Figure 22. Global Hepatitis B Vaccines Revenue Market Share by Company in 2022
    Figure 23. Global Hepatitis B Vaccines Sales Market Share by Geographic Region (2018-2023)
    Figure 24. Global Hepatitis B Vaccines Revenue Market Share by Geographic Region in 2022
    Figure 25. Americas Hepatitis B Vaccines Sales 2018-2023 (M Doses)
    Figure 26. Americas Hepatitis B Vaccines Revenue 2018-2023 ($ Millions)
    Figure 27. APAC Hepatitis B Vaccines Sales 2018-2023 (M Doses)
    Figure 28. APAC Hepatitis B Vaccines Revenue 2018-2023 ($ Millions)
    Figure 29. Europe Hepatitis B Vaccines Sales 2018-2023 (M Doses)
    Figure 30. Europe Hepatitis B Vaccines Revenue 2018-2023 ($ Millions)
    Figure 31. Middle East & Africa Hepatitis B Vaccines Sales 2018-2023 (M Doses)
    Figure 32. Middle East & Africa Hepatitis B Vaccines Revenue 2018-2023 ($ Millions)
    Figure 33. Americas Hepatitis B Vaccines Sales Market Share by Country in 2022
    Figure 34. Americas Hepatitis B Vaccines Revenue Market Share by Country in 2022
    Figure 35. Americas Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
    Figure 36. Americas Hepatitis B Vaccines Sales Market Share by Application (2018-2023)
    Figure 37. United States Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 38. Canada Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 39. Mexico Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Brazil Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 41. APAC Hepatitis B Vaccines Sales Market Share by Region in 2022
    Figure 42. APAC Hepatitis B Vaccines Revenue Market Share by Regions in 2022
    Figure 43. APAC Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
    Figure 44. APAC Hepatitis B Vaccines Sales Market Share by Application (2018-2023)
    Figure 45. China Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 46. Japan Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 47. South Korea Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 48. Southeast Asia Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 49. India Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Australia Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 51. China Taiwan Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 52. Europe Hepatitis B Vaccines Sales Market Share by Country in 2022
    Figure 53. Europe Hepatitis B Vaccines Revenue Market Share by Country in 2022
    Figure 54. Europe Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
    Figure 55. Europe Hepatitis B Vaccines Sales Market Share by Application (2018-2023)
    Figure 56. Germany Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 57. France Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 58. UK Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 59. Italy Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 60. Russia Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country in 2022
    Figure 62. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country in 2022
    Figure 63. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
    Figure 64. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Application (2018-2023)
    Figure 65. Egypt Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 66. South Africa Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 67. Israel Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 68. Turkey Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 69. GCC Country Hepatitis B Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Manufacturing Cost Structure Analysis of Hepatitis B Vaccines in 2022
    Figure 71. Manufacturing Process Analysis of Hepatitis B Vaccines
    Figure 72. Industry Chain Structure of Hepatitis B Vaccines
    Figure 73. Channels of Distribution
    Figure 74. Global Hepatitis B Vaccines Sales Market Forecast by Region (2024-2029)
    Figure 75. Global Hepatitis B Vaccines Revenue Market Share Forecast by Region (2024-2029)
    Figure 76. Global Hepatitis B Vaccines Sales Market Share Forecast by Type (2024-2029)
    Figure 77. Global Hepatitis B Vaccines Revenue Market Share Forecast by Type (2024-2029)
    Figure 78. Global Hepatitis B Vaccines Sales Market Share Forecast by Application (2024-2029)
    Figure 79. Global Hepatitis B Vaccines Revenue Market Share Forecast by Application (2024-2029)

GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape